-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...
More »SEARCH RESULT
India must call the US' bluff on patents-Arvind Panagariya
-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...
More »Smuggled Medicines Save Lives -Ashfaq Yusufzai
-IPS News PESHAWAR, Pakistan- They are contraband, yet a large number of Pakistanis have come to depend on drugs made in India and smuggled into Pakistan. Patients as well as doctors say these are cheap and effective, even as law enforcers look the other way. The two countries do not have a trade agreement on drugs, but markets in Khyber Pakhtunkhwa province in the north of Pakistan do brisk business in India-made...
More »Outside the patent monopolies -Ritu Kamal
-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...
More »GM Crops-What's all the fuss about -Nikhil Inamdar
-The Business Standard A quick recap of the intensely fractured debate on GM crops and what the pro & anti arguments are. After nearly a decade of opposition, Environment Minister Veerappa Moily is finally expected to rule in favour of the contentious GM or genetically modified food crops in India. The Economic Times reports that this will "pave the way for the government to submit an affidavit in the Supreme Court agreeing...
More »